KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 129 filers reported holding KYMERA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $5,541,544 | +14.7% | 222,017 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $4,833,310 | +3.0% | 222,017 | -6.9% | 0.00% | 0.0% |
| Q2 2022 | $4,694,431 | -20.0% | 238,417 | +71.9% | 0.00% | 0.0% |
| Q1 2022 | $5,869,403 | +70.7% | 138,691 | +156.1% | 0.00% | 0.0% |
| Q4 2021 | $3,439,000 | +8.1% | 54,163 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $3,182,000 | +70.9% | 54,163 | +41.1% | 0.00% | – |
| Q2 2021 | $1,862,000 | +117.5% | 38,382 | +74.2% | 0.00% | – |
| Q1 2021 | $856,000 | -8.0% | 22,030 | +46.9% | 0.00% | – |
| Q4 2020 | $930,000 | +91.8% | 15,000 | 0.0% | 0.00% | – |
| Q3 2020 | $485,000 | – | 15,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,858,262 | $173,580,303 | 23.50% |
| Aquilo Capital Management, LLC | 601,325 | $17,817,260 | 7.38% |
| BVF INC/IL | 4,739,004 | $140,416,689 | 5.13% |
| Artal Group S.A. | 1,805,346 | $53,492 | 3.18% |
| Redmile Group, LLC | 2,410,769 | $71,431,085 | 3.10% |
| Avoro Capital Advisors LLC | 3,855,000 | $114,223,650 | 1.69% |
| Deer Management Co. LLC | 615,895 | $18,248,969 | 1.67% |
| AtonRa Partners | 23,779 | $704,572 | 1.03% |
| Rock Springs Capital Management LP | 1,228,379 | $36,396,870 | 0.87% |
| EcoR1 Capital, LLC | 796,093 | $23,588,236 | 0.76% |